EMGLOVI Trademark

Trademark Overview

On Thursday, November 3, 2016, a trademark application was filed for EMGLOVI with the United States Patent and Trademark Office. The USPTO has given the EMGLOVI trademark a serial number of 87225371. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2020. This trademark is owned by Octapharma AG. The EMGLOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, in particular medicines containing immunoglobulins extracted from blood plasma for injections
emglovi

General Information

Serial Number87225371
Word MarkEMGLOVI
Filing DateThursday, November 3, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, in particular medicines containing immunoglobulins extracted from blood plasma for injections
Translation of Words in MarkThe wording "EMGLOVI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 8, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLachen CH-8853
CH

Trademark Events

Event DateEvent Description
Monday, March 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2019EXTENSION 4 GRANTED
Friday, August 2, 2019EXTENSION 4 FILED
Friday, August 2, 2019TEAS EXTENSION RECEIVED
Tuesday, February 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 8, 2019EXTENSION 3 GRANTED
Friday, February 8, 2019EXTENSION 3 FILED
Friday, February 8, 2019TEAS EXTENSION RECEIVED
Wednesday, August 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 6, 2018EXTENSION 2 GRANTED
Monday, August 6, 2018EXTENSION 2 FILED
Monday, August 6, 2018TEAS EXTENSION RECEIVED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2018EXTENSION 1 GRANTED
Thursday, January 18, 2018EXTENSION 1 FILED
Thursday, January 18, 2018TEAS EXTENSION RECEIVED
Tuesday, August 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2017ASSIGNED TO LIE
Tuesday, March 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 13, 2017NON-FINAL ACTION E-MAILED
Monday, February 13, 2017NON-FINAL ACTION WRITTEN
Friday, February 10, 2017ASSIGNED TO EXAMINER
Tuesday, November 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 7, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

emglovi from blood plasma injections extracted immunoglobulins products particular medicines containing